Direct production of 99m Tc using a small medical cyclotron
This project describes an investigation towards the production of 99m Tc with a small medical cyclotron. This endeavor addresses the current urgent problem of availability of 99m Tc due to the ongoing production reactor failures and the upcoming Canadian reactor shut down. Currently, 99m Tc is produced via nuclear fission using highly enriched uranium which is a concern due to nuclear proliferation risks. In addition to this, the United States is dependent solely on currently unreliable foreign sources of this important medical isotope. Clearly, a need exists to probe alternative production routes of 99m Tc. In the first year, this project measured cross-sections and production yields of potential pathways to 99m Tc and associated radionuclidic impurities produced via these pathways using a small 15 MeV medical cyclotron. During the second and third years target systems for the production of 99m Tc via the most promising reaction routes were developed and separation techniques for the isolation of 99m Tc from the irradiated target material will be investigated. Systems for the recycling of the enriched target isotopes as well as automated target processing systems were examined in years four and five. This project has the potential to alleviate some of the current crisis in the medical community by developing a technique to produce 99m Tc on location at a university hospital. This technology will be applicable at many other sites in the United States as many other similar, low energy (<20 MeV) cyclotrons (currently used for a few hours per day for the production of [ 18 F]fluorodeoxyglucose) are available for production of 99m Tc though this method, thus leading to job creation and preservation.